The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.
(JAMA 236:1729-1731, 1976)
Martin WJ, Blumenthal M, Roitman B, Condie R, Simmons R, Najarian J. Antilymphoblast Globulin in Renal Transplant Patients: No Allergic Reactions. JAMA. 1976;236(15):1729–1731. doi:10.1001/jama.1976.03270160051032
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: